在IBD中的 γδT细胞:有益或有害?
Baoqing Xu1,2, Jianbin Ji1, Lingling Ma1
1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Immunology
|June 26, 2025
概括
马三角形T (γδT) 细胞在炎症性肠病 (IBD) 中至关重要. 它们在IBD中的作用是有争议的,但 γδT细胞疗法在治疗这种免疫疾病方面表现有前途.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 细胞生物学 细胞生物学
背景情况:
- 马三角形T (γδT) 细胞是免疫细胞,涉及各种炎症状况.
- 它们在炎症性肠病 (IBD) 发病过程中的确切作用尚不清楚,关于它们的有益或有害影响的证据是相互矛盾的.
- 现有的文献主要集中在其他自身免疫性疾病中的 γδT 细胞上,在IBD 特定的综合性审查中留下了一个空白.
研究的目的:
- 在炎症性肠病 (IBD) 的背景下,总结目前对 γδT 细胞的理解.
- 巩固有关IBD期间 γδT细胞变化的特征和功能的发现.
- 突出基于γδT细胞的IBD治疗策略的新兴潜力.
主要方法:
- 现有关于 γδT 细胞和IBD 的研究的文献综述.
- 分析研究的 γδT 细胞子集,细胞因子档案,并在IBD模型和患者的变化.
- 综合证据关于肠炎中 γδT 细胞的双重作用 (保护性与有害性).
主要成果:
- 在IBD中, γδT细胞数量,子集和分泌的细胞因子明显变化.
- 证据支持大肠炎中gδT细胞的保护性和加剧性作用,这表明它们的功能取决于环境.
- 基于 γδT 细胞的疗法正在被探索为IBD的潜在治疗途径.
结论:
- γδT细胞是IBD的关键参与者,但它们的净效应是复杂的和争论的.
- 需要进行进一步的研究,以阐明 γδT 细胞影响 IBD 的具体机制.
- 向γδT细胞代表了新的IBD疗法的一个有希望的前沿.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
240
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
240
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Inflammatory Bowel Disease IV: Pharmacological Management
204
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
204
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278
Inflammatory Bowel Disease I: Ulcerative Colitis
345
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
345


